Phenomenex Introduces New bioZen Nano 75 µm LC Columns

Torrance, Calif. (February 22, 2021) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the launch of the bioZen Nano 75 µm LC Columns to the existing portfolio of  bioZen biological workflow products. The New bioZen Nano Columns offers a powerful combination two advanced particle platforms,... Read more

Pristine Sample Preparation For SEM Using Broad Ion Beam Milling

Feb. 22, 2021 Peabody, Mass. – JEOL USA introduces a new configuration of its bestselling broad ion beam milling instrument, the Cross-section Polisher (CP). The CP is widely used for preparing pristine samples prior to high resolution imaging and elemental analysis with the Scanning Electron Microscope (SEM).  The upgraded configuration includes high-speed milling, sputter coating, cryo-preparation (down... Read more

Phenomenex Introduces NEW SINGLE GC Solution for Dioxin Analysis

Torrance, Calif. (February 19, 2021) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences introduces Zebron™ ZB-Dioxin . Zebron ZB-Dioxin joins Phenomenex’s large family of GC unlimited Phase to deliver optimal performance when analyzing regulated 2,3,7,8-tetrachlorodibenzo- para-dioxin (2,3,7,8-TCDD) and 2,3,7,8 tetrachlorodibenzo- para-furan(TCDF).  EPA-1613 and EPA-8290 Dioxin methods requires... Read more

Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies

Kit marks first of multiple planned for 2021 aimed at COVID-19  SANTA CLARA, Calif., February 18, 2021  Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which... Read more

Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis

Enhanced data quality, easier workflow, and more versatile analytics using fewer cell numbers SANTA CLARA, Calif., February 17, 2021  Agilent Technologies Inc. (NYSE: A) today introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Agilent Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis. Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered... Read more

PerkinElmer Launches First Cell Painting Kit

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside the Company’s microplates, automation, software and industry-leading... Read more

FDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit

One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B CARLSBAD, Calif., Feb. 16, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit from Thermo Fisher Scientific, the company announced... Read more

New phase III data show Roche’s faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in two leading causes of vision loss, potentially reducing treatment burden for patients

Across four studies in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), approximately half of people receiving faricimab could be treated every four months in the first year Approximately three-quarters of people receiving faricimab could be treated every three months or longer in the first year Faricimab showed rapid and consistent improvements in... Read more